Amikhelline is an antimitotic drug.[1] It acts as a DNA intercalator[2] and inhibits DNA polymerase.[3]

Amikhelline
Clinical data
ATC code
  • none
Pharmacokinetic data
Metabolismnone
Identifiers
  • 9-(2-diethylaminoethoxy)-4-hydroxy-7-methylpyrano[3,2-f][1]benzoxol-5-one
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H21NO5
Molar mass331.368 g·mol−1
3D model (JSmol)
  • O=C/1c3c(O\C(=C\1)C)c(OCCN(CC)CC)c2occc2c3O
  • InChI=1S/C18H21NO5/c1-4-19(5-2)7-9-23-18-16-12(6-8-22-16)15(21)14-13(20)10-11(3)24-17(14)18/h6,8,10,21H,4-5,7,9H2,1-3H3 checkY
  • Key:QZBPFSZZMYTRIA-UHFFFAOYSA-N checkY
  (verify)

References

edit
  1. ^ Turchini MF, Geneix A, Perissel B, Malet P, Turchini JP (1985). "[Characterization of chromosomal aberrations induced in man by various antimitotic agents]". Comptes Rendus des Séances de la Société de Biologie et de ses Filiales. 179 (3): 331–9. PMID 2417673.
  2. ^ Rucheton M, Jeanteur P (1973). "Studies on amikhellin. I. Intercalative binding to double-stranded DNA". Biochimie. 55 (11): 1415–20. doi:10.1016/s0300-9084(74)80548-1. PMID 4364376.
  3. ^ Rucheton M, Jeanteur P (1976). "Studies on amikhellin. II.-Inhibition of dna-polymerase from murine sarcoma leukemia virus". Biochimie. 58 (6): 689–95. doi:10.1016/s0300-9084(76)80393-8. PMID 60141.